Main > ONCOLOGY (**) > GEJ Cancer MET or R PD-L1+ *** > Treatment > USA. T. Trifluridine+Tipiracil>

---

USA. T. Trifluridine+Tipiracil>'s subsections
(*) USA Approval Date: 2019. 02.25.
>Previously Treat.>2 CT>
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 2
Patent>UpDate: 2019. 02.19
TradeMark
TradeMark Web-Site

USA. T. Trifluridine+Tipiracil>'s products
This section has no products